Search Results - "Eivind Berge"

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis by Wardlaw, Joanna M, Prof, Murray, Veronica, Prof, Berge, Eivind, Prof, del Zoppo, Gregory, Prof, Sandercock, Peter, Prof, Lindley, Richard L, Prof, Cohen, Geoff, PhD

“…Summary Background Recombinant tissue plasminogen activator (rt-PA, alteplase) improved functional outcome in patients treated soon after acute ischaemic…”
Get full text

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis by Pinho-Gomes, Ana-Catarina, Azevedo, Luis, Copland, Emma, Canoy, Dexter, Nazarzadeh, Milad, Ramakrishnan, Rema, Berge, Eivind, Sundström, Johan, Kotecha, Dipak, Woodward, Mark, Teo, Koon, Davis, Barry R, Chalmers, John, Pepine, Carl J, Rahimi, Kazem

“…Background Randomised evidence on the efficacy of blood pressure (BP)-lowering treatment to reduce cardiovascular risk in patients with atrial fibrillation…”
Get full text

Effects of Blood Pressure and Blood Pressure–Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke by Berge, Eivind, Cohen, Geoffrey, Lindley, Richard I, Sandercock, Peter, Wardlaw, Joanna M, Sandset, Else C, Whiteley, William

“…BACKGROUND AND PURPOSE—In patients with acute ischemic stroke, a high blood pressure or a highly variable blood pressure is a common reason for withholding…”
Get full text

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial by Sandset, Else Charlotte, MD, Bath, Philip MW, Prof, Boysen, Gudrun, Prof, Jatuzis, Dalius, MD, Kõrv, Janika, MD, Lüders, Stephan, MD, Murray, Gordon D, Prof, Richter, Przemyslaw S, MD, Roine, Risto O, Prof, Terént, Andreas, Prof, Thijs, Vincent, MD, Berge, Eivind, Dr

“…Summary Background Raised blood pressure is common in acute stroke, and is associated with an increased risk of poor outcomes. We aimed to examine whether…”
Get full text

Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men by Prestgaard, Erik, Mariampillai, Julian, Engeseth, Kristian, Erikssen, Jan, Bodegård, Johan, Liestøl, Knut, Kjeldsen, Sverre, Grundvold, Irene, Berge, Eivind

“…BACKGROUND AND PURPOSE—The importance of weight change for the risk of stroke is not well known. We examined the associations between early- and mid-life…”
Get full text

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data by Karmali, Kunal N, Lloyd-Jones, Donald M, van der Leeuw, Joep, Goff, Jr, David C, Yusuf, Salim, Zanchetti, Alberto, Glasziou, Paul, Jackson, Rodney, Woodward, Mark, Rodgers, Anthony, Neal, Bruce C, Berge, Eivind, Teo, Koon, Davis, Barry R, Chalmers, John, Pepine, Carl, Rahimi, Kazem, Sundström, Johan

“…Clinical practice guidelines have traditionally recommended blood pressure treatment based primarily on blood pressure thresholds. In contrast, using predicted…”
Get full text

Blood Pressure–Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers by Mehlum, Maria H., Liestøl, Knut, Kjeldsen, Sverre E., Wyller, Torgeir B., Julius, Stevo, Rothwell, Peter M., Mancia, Giuseppe, Parati, Gianfranco, Weber, Michael A., Berge, Eivind

“…Blood pressure–lowering drugs have different blood pressure–lowering profiles. We studied if differences in blood pressure mean and variability can explain the…”
Get full text

Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage by Seiffge, David J., Kägi, Georg, Michel, Patrik, Fischer, Urs, Béjot, Yannick, Wegener, Susanne, Zedde, Marialuisa, Turc, Guillaume, Cordonnier, Charlotte, Sandor, Peter S., Rodier, Gilles, Zini, Andrea, Cappellari, Manuel, Schädelin, Sabine, Polymeris, Alexandros A., Werring, David, Thilemann, Sebastian, Maestrini, Ilaria, Berge, Eivind, Traenka, Christopher, Vehoff, Jochen, De Marchis, Gian Marco, Kapauer, Monika, Peters, Nils, Sirimarco, Gaia, Bonati, Leo H., Arnold, Marcel, Lyrer, Philippe A., De Maistre, Emmanuel, Luft, Andreas, Tsakiris, Dimtrios A., Engelter, Stefan T.

“…Objective Information about rivaroxaban plasma level (RivLev) may guide treatment decisions in patients with acute ischemic stroke (AIS) and intracerebral…”
Get full text

Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials by Coutts, Shelagh B, Berge, Eivind, Campbell, Bruce CV, Muir, Keith W, Parsons, Mark W

“…Alteplase has been the mainstay of thrombolytic treatment since the National Institutes of Neurological Disorders and Stroke trial was published in 1995. Over…”
Get full text

Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials by Whiteley, William N, Dr, Adams, Harold P, MD, Bath, Philip MW, FRCP, Berge, Eivind, MD, Sandset, Per Morten, MD, Dennis, Martin, MD, Murray, Gordon D, PhD, Wong, Ka-Sing Lawrence, MD, Sandercock, Peter AG, MD

“…Summary Background Many international guidelines on the prevention of venous thromboembolism recommend targeting heparin treatment at patients with stroke who…”
Get full text

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events by Atar, Dan, Berge, Eivind, Le Heuzey, Jean-Yves, Virdone, Saverio, Camm, A John, Steffel, Jan, Gibbs, Harry, Goldhaber, Samuel Z, Goto, Shinya, Kayani, Gloria, Misselwitz, Frank, Stepinska, Janina, Turpie, Alexander G G, Bassand, Jean-Pierre, Kakkar, Ajay K

“…Abstract Aims Guidelines do not recommend to take pattern of atrial fibrillation (AF) into account for the indication of anticoagulation (AC). We assessed AF…”
Get full text

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial by Berge, Eivind, Prof, Cohen, Geoffrey, MSc, Roaldsen, Melinda B, MD, Lundström, Erik, MD, Isaksson, Eva, BN, Rudberg, Ann-Sofie, MD, Slot, Karsten Bruins, MD, Forbes, John, Prof, Smith, Joel, PhD, Drever, Jonathan, BSc, Wardlaw, Joanna M, Prof, Lindley, Richard I, Prof, Sandercock, Peter A G, Prof, Whiteley, William N, MD

“…Summary Background The effect of alteplase on patient survival after ischaemic stroke is the subject of debate. We report the effect of intravenous alteplase…”
Get full text

Increasing value and reducing waste in stroke research by Berge, Eivind, PhD, Salman, Rustam Al-Shahi, Prof, van der Worp, H Bart, PhD, Stapf, Christian, Prof, Sandercock, Peter, Prof, Sprigg, Nikola, DM, Macleod, Malcolm R, Prof, Kelly, Peter J, Prof, Nederkoorn, Paul J, MD, Ford, Gary A, MD

“…Summary Stroke is a major burden to patients and society, and resources spent on stroke research must be used efficiently and produce good value in terms of…”
Get full text

Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke by Appleton, Jason P., Woodhouse, Lisa J., Adami, Alessandro, Becker, Jennifer L., Berge, Eivind, Cala, Lesley A., Casado, Ana M., Caso, Valeria, Christensen, Hanne K., Dineen, Robert A., Gommans, John, Koumellis, Panos, Szatmari, Szabolcs, Sprigg, Nikola, Bath, Philip M., Wardlaw, Joanna M.

Get full text

Relation Between Change in Blood Pressure in Acute Stroke and Risk of Early Adverse Events and Poor Outcome by SANDSET, Else C, MURRAY, Gordon D, BATH, Philip M. W, KJELDSEN, Sverre E, BERGE, Eivind

“…The Scandinavian Candesartan Acute Stroke Trial (SCAST) found no benefits of candesartan in acute stroke. In the present analysis we aim to investigate the…”
Get full text

Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial by Maria H. Mehlum, Knut Liestøl, Torgeir B. Wyller, Tsushung A. Hua, Morten Rostrup, Eivind Berge

“…Purpose: Blood pressure variability is associated with traditional cardiovascular risk factors, but little is known about the association with atrial…”
Get full text

Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial by Godolphin, Peter J, Montgomery, Alan A, Woodhouse, Lisa J, Bereczki, Daniel, Berge, Eivind, Collins, Rónán, Díez-Tejedor, Exuperio, Gommans, John, Lees, Kennedy R, Ozturk, Serefnur, Phillips, Stephen, Pocock, Stuart, Prasad, Kameshwar, Szatmari, Szabolcs, Wang, Yongjun, Bath, Philip M, Sprigg, Nikola

“…Central adjudication of serious adverse events (SAEs) can be undertaken in clinical trials, especially for open-label studies where outcome assessment may be…”
Get full text

Cost-benefit of outcome adjudication in nine randomised stroke trials by Godolphin, Peter J, Bath, Philip M, Algra, Ale, Berge, Eivind, Chalmers, John, Eliasziw, Misha, Hankey, Graeme J, Hosomi, Naohisa, Ranta, Annamarei, Weimar, Christian, Woodhouse, Lisa J, Montgomery, Alan A

“…Background Central adjudication of outcomes is common for randomised trials and should control for differential misclassification. However, few studies have…”
Get full text

Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke by Appleton, Jason P, Woodhouse, Lisa J, Bereczki, Daniel, Berge, Eivind, Christensen, Hanne K, Collins, Rónán, Gommans, John, Ntaios, George, Ozturk, Serefnur, Szatmari, Szabolcs, Wardlaw, Joanna M, Sprigg, Nikola, Rothwell, Peter M, Bath, Philip M

“…Background and Purpose- Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated…”
Get full text

How to do a systematic review by Pollock, Alex, Berge, Eivind

“…High quality up-to-date systematic reviews are essential in order to help healthcare practitioners and researchers keep up-to-date with a large and rapidly…”
Get full text